Botox Settlement Adds More Frown Lines To Industry
On Sept. 1, the U.S. Department of Justice announced the resolution of an investigation into alleged off-label marketing of Botox by Allergan Inc....To view the full article, register now.
Already a subscriber? Click here to view full article